GlassScriptPhysician profile
Laurel A Yeager
NPI 1174585160
$677.02
in general payments reported to CMS, 2019-2025
14 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.23 · 2020: $98.03 · 2021: $46.16 · 2022: $176 · 2023: $133 · 2024: $24.04 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $121.85 | 2023-2025 | Plasmablade(Tm), Signia |
| Endomagnetics LTD | $91.70 | 2019-2020 | |
| Ethicon US, LLC | $77.20 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $74.94 | 2022-2025 | Myrisk |
| Covidien LP | $65.05 | 2019 | |
| Innocoll Pharmaceuticals Limited | $58.88 | 2021-2022 | |
| Heron Therapeutics, INC. | $37.76 | 2022-2025 | Zynrelef |
| Intuitive Surgical, INC. | $33.20 | 2025 | |
| Integra Lifesciences Corporation | $28.33 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Solventum Corporation | $24.04 | 2024 | Prevena |
| Dilon Technologies, INC. | $17.45 | 2021 | |
| Axonics, INC. | $17.44 | 2022 | |
| Elucent Medical | $16.04 | 2025 | |
| Cook Medical LLC | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Yeager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.